Health ❯ Healthcare ❯ Patient Outcomes

Adverse Events

Mortality Rates Clinical Study Results Never Events Major Bleeding Mortality Risks Hyperkalemia Long-term Follow-up Death Investigations Cardiopulmonary Decompensation Gastrointestinal Symptoms

3 ARTICLES

2d ago

DOACs Cut Stroke and Cardiovascular Events Without Raising Major Bleeding in Intermediate‑Risk AF, SINGLE‑AF Finds

The randomized trial offers the first clear evidence that could prompt guideline revisions or broader reimbursement for patients with one CHA2DS2‑VASc risk point.

5 ARTICLES

2mo ago

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

3 ARTICLES

3mo ago

Saitama Children’s Hospital Panel Reviews Cluster of Neurological Injuries After Intrathecal Chemotherapy

8 ARTICLES

5mo ago

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

3 ARTICLES

5mo ago

HI-PEITHO Finds Catheter Ultrasound Thrombolysis Halves 30-Day Events in Intermediate-Risk PE

9 ARTICLES

7mo ago

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

6 ARTICLES

9mo ago

Repatha Cuts First Major Cardiac Events by 25% in At-Risk Adults in AHA Trial

5 ARTICLES

10mo ago

TCT 2025: Stent‑Sparing Balloons Match DES at One Year as Lower‑Cost Alternatives Rival IVL

10 ARTICLES

11mo ago

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

7 ARTICLES

last yr.

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

9 ARTICLES

2y ago

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks